These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 37100351)
1. Morphine and dopamine: Low dose apomorphine can prevent both the induction and expression of morphine locomotor sensitization and conditioning. Leite Júnior JB; Carvalho Crespo LGS; Samuels RI; Coimbra NC; Carey RJ; Carrera MP Behav Brain Res; 2023 Jun; 448():114434. PubMed ID: 37100351 [TBL] [Abstract][Full Text] [Related]
2. Reversal of morphine conditioned behavior by an anti-dopaminergic post-trial drug treatment during re-consolidation. Leite Junior JB; de Mello Bastos JM; Samuels RI; Carey RJ; Carrera MP Behav Brain Res; 2019 Feb; 359():771-782. PubMed ID: 30114434 [TBL] [Abstract][Full Text] [Related]
3. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response. Dias FR; Carey RJ; Carrera MP Brain Res; 2006 Apr; 1083(1):85-95. PubMed ID: 16530737 [TBL] [Abstract][Full Text] [Related]
4. ERK activation in the prefrontal cortex by acute apomorphine and apomorphine conditioned contextual stimuli. Sanguedo FV; Figueiredo AM; Carey RJ; Samuels RI; Carrera MP Pharmacol Biochem Behav; 2017 Aug; 159():76-83. PubMed ID: 28739380 [TBL] [Abstract][Full Text] [Related]
5. Medial prefrontal cortex ERK and conditioning: Evidence for the association of increased medial prefrontal cortex ERK with the presence/absence of apomorphine conditioned behavior using a unique post-trial conditioning/extinction protocol. Sanguedo FVC; Samuels RI; Carey RJ; Carrera MP Behav Brain Res; 2019 Jun; 365():56-65. PubMed ID: 30779974 [TBL] [Abstract][Full Text] [Related]
6. Post-trial apomorphine at an autoreceptor dose level can eliminate apomorphine conditioning and sensitization: support for the critical role of dopamine in re-consolidation. Carrera MP; Carey RJ; Cruz Dias FR; Dos Santos Sampaio MF; de Matos LW Behav Brain Res; 2013 Jan; 236(1):244-250. PubMed ID: 22759753 [TBL] [Abstract][Full Text] [Related]
7. Morphine reward effects and morphine behavioral sensitization: The adventitious association of morphine activation of brain reward effects with ongoing spontaneous activity. Dias FP; Carvalho Crespo LGS; Leite Junior JB; Samuels RI; Coimbra NC; Carey RJ; Carrera MP Pharmacol Biochem Behav; 2021 Oct; 209():173244. PubMed ID: 34363828 [TBL] [Abstract][Full Text] [Related]
8. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning. Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine. Mattingly BA; Caudill A; Abel M Pharmacol Biochem Behav; 2001 Mar; 68(3):417-26. PubMed ID: 11325394 [TBL] [Abstract][Full Text] [Related]
10. Post-trial low dose apomorphine prevents the development of morphine sensitization. de Mello Bastos JM; Leite JB; Samuels RI; Carey RJ; Carrera MP Behav Brain Res; 2020 Feb; 380():112398. PubMed ID: 31790782 [TBL] [Abstract][Full Text] [Related]
11. Low dose apomorphine induces context-specific sensitization of hypolocomotion without conditioning: support for a new state dependent retrieval hypothesis of drug conditioning and sensitization. Braga PQ; Dias FR; Carey RJ; Carrera MP Pharmacol Biochem Behav; 2009 Aug; 93(2):128-33. PubMed ID: 19414026 [TBL] [Abstract][Full Text] [Related]
12. Residual dopamine receptor desensitization following either high- or low-dose sub-chronic prior exposure to the atypical anti-psychotic drug olanzapine. Dias FR; de Matos LW; Dos Santos Sampaio Mde F; Carey RJ; Carrera MP Psychopharmacology (Berl); 2013 Jan; 225(1):141-50. PubMed ID: 22825579 [TBL] [Abstract][Full Text] [Related]
13. Context evoked morphine conditioned effects can be equivalent to morphine induced drug effects in terms of behavioral response and ERK activation in reward associated subcortical brain structures. Crespo LGSC; Leite Júnior JB; de Mello Bastos JM; Samuels RI; Coimbra NC; Carey RJ; Carrera MP Pharmacol Biochem Behav; 2022 Mar; 214():173356. PubMed ID: 35181379 [TBL] [Abstract][Full Text] [Related]
15. Drug conditioning induced by intrastriatal apomorphine administration. Pinheiro Carrera M; Brunhara FC; Schwarting RK; Tomaz C Brain Res; 1998 Apr; 790(1-2):60-6. PubMed ID: 9593824 [TBL] [Abstract][Full Text] [Related]
16. Repeated pre-trial and post-trial low and high dose apomorphine treatments induce comparable inhibitory/excitatory sensitization and conditioned drug effects. Santos BG; Carey RJ; Carrera MP Pharmacol Biochem Behav; 2018 Dec; 175():108-115. PubMed ID: 30267795 [TBL] [Abstract][Full Text] [Related]
17. Stimulus and response factors affecting the development of behavioral sensitization to apomorphine. Mattingly BA; Koch C; Osborne FH; Gotsick JE Psychopharmacology (Berl); 1997 Mar; 130(2):109-16. PubMed ID: 9106907 [TBL] [Abstract][Full Text] [Related]
18. Drug memory substitution during re-consolidation: a single inhibitory autoreceptor apomorphine treatment given during psychostimulant memory re-consolidation replaces psychostimulant conditioning with conditioned inhibition and reverses psychostimulant sensitization. de Mello Bastos JM; Dias FR; Alves VH; Carey RJ; Carrera MP Behav Brain Res; 2014 Mar; 260():139-47. PubMed ID: 24239895 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of apomorphine-induced conditioned place preference in rats co-injected with buspirone: relationship with serotonin and dopamine in the striatum. Haleem DJ; Ikram H; Haleem MA Brain Res; 2014 Oct; 1586():73-82. PubMed ID: 25160128 [TBL] [Abstract][Full Text] [Related]
20. Increase in medial frontal cortex ERK activation following the induction of apomorphine sensitization. Sanguedo FV; Dias FR; Bloise E; Cespedes IC; Giraldi-Guimarães A; Samuels RI; Carey RJ; Carrera MP Pharmacol Biochem Behav; 2014 Mar; 118():60-8. PubMed ID: 24380761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]